Predicting candidemia in internal medicine departments: are we chasing the Holy Grail?
Anno:
2021
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Formato:
Elettronico
Referee:
Sì
Nome rivista:
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ
ISSN Rivista:
1897-9483
N° Volume:
131
Numero o Fascicolo:
11
Intervallo pagine:
16112-16114
Parole chiave:
canidemia; internal medicine; beta-D-glucan
Breve descrizione dei contenuti:
Candidemia is a challenging clinical condition with high rates of morbidity and mortality.1 Key requirements for its prompt management include early identification and timely initiation of appropriate systemic antifungal therapy, consistently reported as a major determinant of survival. However, the diagnosis of candidemia can be challenging and is often delayed as there are no specific clinical signs, blood cultures have low sensitivity, and detection of fungal blood cultures takes a long time. In addition, there is evidence that a significant percentage of such infections occurs in patients admitted to internal medicine departments. This is not particularly surprising given the advanced age of many inpatients at internal medicine departments and multiple complex comorbidities. Moreover, related therapies and healthcare system contacts often involve the use of central venous catheters and other indwelling devices, potentially entailing high risk of candidemia.2 Therefore, optimization of the diagnostic and therapeutic approach is an important and still unfulfilled need for the management of candidemia in internal medicine departments
Id prodotto:
125045
Handle IRIS:
11562/1058257
ultima modifica:
3 marzo 2024
Citazione bibliografica:
Pieralli, F; Azzini, Am; Concia, E; Lo Cascio, G; Tedesco, A; Benedetti, V; Piredda, S; Giusti, M; Santini, C; Zagarrì, E; Fontanella, A; Manfellotto, D.,
Predicting candidemia in internal medicine departments: are we chasing the Holy Grail?«POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ»
, vol. 131
, n. 11
, 2021
, pp. 16112-16114